Our pathway-level analysis revealed that CYP-epoxygenase overexpression and activation are related to facilitating different cancer-related networks unique for each breast cancer subtype and also highlights pathways which are known to be universal drivers in breast cancer progression, e.g., MAPK, NOTCH, hedgehog and c-Myc transcription factor signaling. The gene discussed is NME2; the disease is cancer.